Tu carrito

tommee tippee - reemplazo avanzado de tetina para biberón anticólicos, flujo rápido, 6 meses o más, 2 unidades

  • $CLP 19.984

TÉRMINOS Y CONDICIONES

------------------------------------------

- El producto se trae a pedido, en un transcurso de 15 a 25 dias, si alguna restriccion de un ente gubernamental o de salud publica cambia o restringe vuelos, los pedidos pueden demorar mas tiempo.
- Precios pueden cambiar previo aviso. Depende de precio con proveedores o existencia.
- Fotos referenciales del producto, consulte no mas
- Despachamos a todo Chile con Starken.
- Productos importados de Estados Unidos, es probable que los productos electronicos trabajen en 110V y NO en 220V, podria usar un transformador, para mas informacion primero nos puedes preguntar todas las inquietudes que tengas.


- Fast Flow (size 3) nipple, COMPATIBLE WITH ADVANCED ANTI-COLIC BOTTLES ONLY
- Recommended for babies age 6 months and up
- Award-winning breast-like nipple for a natural latch and seamless transition from breast to bottle
- The Advanced Anti-Colic bottle is designed to reduce colic symptoms for less gas, spit up and discomfort
- Unique anti-colic venting system in the bottle draws air away from milk
- BPA free and phthalate-free for ultimate reassurance


Color:Fast Flow"There's nothing a parent wants more than for their baby to be comfortable, that's why we've combined our award-winning breast-like nipple with the latest anti-colic innovation to create the Tommee Tippee Advanced Anti-Colic bottle. This is no ordinary baby bottle. It works a little differently from regular bottles to help combat colic, while ensuring a comfortable feeding experience for you and your baby. The unique venting system draws air away from milk, meaning 80% less gas*, and 100% more smiles! Plus, a built-in heat-sensing strip gives extra reassurance that your milk is just the right temperature. Helping you #ParentOn * When we asked 210 parents who tried using this product to reduce their childs colic symptoms, 80% agreed the bottle had successfully reduced the symptoms (June 2017). "